academic article

• Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York..  JAMA health forum.  3:-. 2022
• Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness..  Cognitive, affective & behavioral neuroscience.  19:1047-1058. 2019
• A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation..  Cognitive Behaviour Therapy.  48:65-76. 2018
• Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy..  Journal of Dual Diagnosis.  13:168-178. 2017
• Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy..  Addictive Behaviors.  89-95. 2017
• Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder..  Schizophrenia Research.  124-129. 2016
• Early onset marijuana use is associated with learning inefficiencies..  Neuropsychology.  30:405-15. 2016
• Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial..  Journal of Clinical Psychiatry.  77:e320-6. 2016
• Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial..  JAMA.  311:145-54. 2014
• Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia..  Psychopharmacology.  231:765-75. 2013